SCHEMBL7986914

SCHEMBL7986914

Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN(c4ccccn4)CC3)cc2n2cncc12

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969609 0.88 LCK (1.00) LCK
SCHEMBL7980289 0.87 LCK (0.85) LCK
SCHEMBL7983587 0.86 LCK (1.00) LCK
SCHEMBL4042111 0.86 LCK (0.69) LCK
SCHEMBL7986900 0.85 LCK (1.00) LCK
SCHEMBL7983586 0.85 LCK (1.00) LCK
SCHEMBL7969586 0.85 LCK (1.00) LCK
SCHEMBL7981062 0.85 LCK (1.00) LCK
SCHEMBL7986986 0.84 LCK (0.79) LCK
SCHEMBL7981745 0.83 LCK (0.86) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed